Skip to main content
57kviews
Editorial: Spatiotemporal heterogeneity in CNS tumors
Editorial29 May 2024
Editorial: Spatiotemporal heterogeneity in CNS tumors

Dynamic shifts in the glioma microenvironment: from 'Cold' to 'Hot' tumors. This figure illustrates the dynamic shifts within the glioma TME, comparing the immunologically 'cold' tumor states characterized by pre-existing resistance with the 'hot' tumor states that arise posttherapeutic interventions. It delineates how 'cold' tumors, which exhibit minimal immune activity and inherent resistance, can transition to 'hot' tumors, which are more responsive to immune interventions. However, these 'hot' tumors can revert to 'cold' states due to acquired resistance, emphasizing the need for spatiotemporal analysis. Such analyses, including single-cell transcriptomics, multiplex immunohistochemistry, imaging mass cytometry, in vivo time-lapse microscopy, and 3D mapping, are essential to continuously adapt and optimize therapeutic strategies. By precisely mapping the temporal and spatial immune landscape, neurooncologists can better manage treatment protocols and enhance the efficacy of interventions against glioma. Collado et al. discusses the role of the extracellular matrix (ECM) in modulating immune responses within the GBM TME, illustrating how ECM-associated proteins inhibit the efficacy of immunotherapies through complex interactions with tumor and immune cells. Understanding the impacts of these proteins, their perspective highlights their significant roles in tumor growth and immune cell infiltration. Previously, we demonstrated that COL1A1 serves as an actionable target to disrupt glioma progression through spatiotemporal analysis of glioma heterogeneity. 9 We also developed an in vitro model to study glioma dynamics. 10 The authors propose that manipulating the ECM could enhance immune cell infiltration and consequently, the efficacy of immunotherapy, opening new avenues for treatment strategies. This research topic brings together cutting-edge studies that employ spatial biology to delve into the depth of GBM heterogeneity, offering a comprehensive view of the complexities of glioma.From detailing the peritumoral brain zones to exploring the implications of immune cell infiltration and cellular plasticity, the contributions within this collection offer a comprehensive overview of the current landscape and suggest promising future directions in glioma research. Each article not only advances our understanding of spatiotemporal tumor dynamics but also emphasizes the potential of spatial transcriptomics as a beacon for the development of novel therapeutic strategies and combinational treatments aimed at overcoming therapeutic resistance in glioma. As we continue to explore these innovative approaches, we will move to a future where our enhanced understanding translates into significantly improved outcomes for patients.

2,508 views

3 citations

ORIGINAL RESEARCH
17 January 2024
The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, 19 more and Jason Miska

7,712 views

29 citations

ORIGINAL RESEARCH
10 January 2024
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma
David Hou, 19 more and Catalina Lee-Chang

8,505 views

20 citations